Korro Bio Inc (NAS:KRRO)
$ 12.17 -1.61 (-11.68%) Market Cap: 175.52 Mil Enterprise Value: 104.44 Mil PE Ratio: 0 PB Ratio: 1.47 GF Score: 6/100

Korro Bio Inc at JPMorgan Healthcare Conference Transcript

Jan 15, 2026 / 09:30PM GMT
Release Date Price: $8.8 (-2.22%)
Henry Jiang
JPMorgan - Analyst

Hi everyone, good morning. Thank you all for joining us today. My name is Henry Jiang. I'm with the banking team here at JP Morgan and it's my pleasure to be introducing Korro Bio today. Joining us on stage and presenting will be Ram Aiyar, President and CEO of Korro Bio. Just a quick note, we'll have some time after the presentation for questions, so please wait, until then, but without further ado, I'll pass it over to you, Ram.

Ram Aiyar;Principal Executive Officer;Interim Chief Financial Officer and Principal Financial Officer
Korro Bio Inc - President, Chief Executive Office;Director

(), -

So thank you for the JPMorgan Healthcare team for giving us the opportunity to present here today. It's great to see this amazing crowd here. So thank you for being here. Really appreciate it. Hopefully, we'll tell you a little bit about what we do at Korro. Here are my customary forward-looking statements. You can always go to the SEC to find our most latest filings.

So what do we do at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot